GET DAILY SIGNALSIchor Holdings (ICHR) Holds Steady at $90.41 After +4% Monthly Gain
Key Takeaways
- Ichor Holdings shares traded at $90.41 as of July 13, 2026, gaining approximately 4% over the prior 30 days amid continued semiconductor equipment demand momentum.
- First quarter 2026 revenue reached $256.1 million, exceeding analyst expectations, while non-GAAP EPS of $0.15 beat the consensus estimate of $0.13.
- Management guided for Q2 2026 revenue between $290 million and $310 million, projecting another quarter of sequential improvement across revenue, gross margin, and earnings per share.
- Multiple Wall Street analysts raised price targets significantly, with B. Riley setting a $125 target and TD Cowen and Stifel Nicolaus each raising targets to $115.
- The company was reclassified into Russell Growth indexes in late June 2026, signaling a shift in market perception toward a growth-oriented profile.
- Q2 2026 earnings are scheduled for release on August 3, with margin expansion trends and forward guidance serving as critical investor watchpoints.
Where Ichor Holdings Stands in Today’s Market
Ichor Holdings (ICHR) has navigated a volatile yet upward-trending market environment over the past several months. As of the July 13, 2026 close, shares settled at $90.41, reflecting a modest gain of roughly 4% from the $86.80 level recorded 30 days earlier on June 12. The stock has experienced substantial swings, touching a 52-week high of $113.58 on July 1 before pulling back amid broader sector rotation and profit-taking. The 50-day moving average stands at approximately $81.89, while the 200-day moving average sits near $56.34, underscoring the stock’s significant longer-term appreciation. With a market capitalization of approximately $3.15 billion and institutional ownership at 94.81%, ICHR remains firmly on the radar of professional investors focused on semiconductor capital equipment exposure. Elevated trading volumes during earnings and index rebalancing periods indicate sustained market interest in the name.
Ichor’s Position in the Semiconductor Equipment Chain
Ichor Holdings, Ltd. is a global leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The company’s primary products include gas delivery subsystems that precisely control specialized gases used in etch and deposition processes, and chemical delivery subsystems that blend and dispense reactive liquid chemistries for processes such as chemical-mechanical planarization and electroplating. Ichor also supplies precision-machined components, weldments, and surface treatment technologies. Headquartered in Fremont, California, with manufacturing operations spanning the United States, Malaysia, Singapore, and Europe, the company serves major semiconductor equipment original equipment manufacturers (OEMs). Its competitive edge lies in deep process expertise, vertically integrated manufacturing capabilities, and long-standing relationships with industry leaders such as LRCX and AMAT. Ichor is also diversifying into adjacent markets including defense, aerospace, and medical, with its commercial space business gaining meaningful traction in 2026. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Catalysts Behind the Recent Price Action
Several catalysts have shaped Ichor’s market narrative over the past 30 days. The company’s Q1 2026 earnings report, released on May 4, demonstrated strengthening operational momentum with revenue of $256.1 million, up 15% sequentially and 4.7% year-over-year. Non-GAAP gross margin improved to 12.8%, and management delivered an optimistic Q2 outlook projecting revenue between $290 million and $310 million alongside non-GAAP EPS of $0.25 to $0.35, reflecting expectations for accelerating customer delivery timelines. This earnings beat sparked a wave of analyst activity: B. Riley raised its price target to $125, TD Cowen and Stifel Nicolaus each lifted targets to $115, and Zacks Research upgraded the stock to a Strong-Buy rating on July 3. On June 27, Ichor was reclassified into multiple Russell Growth indexes, including the Russell 3000 Growth and Russell 2000 Growth benchmarks, a move that can influence passive fund flows and reshape institutional positioning. Insider selling drew some attention, including CEO Philip Barros’s sale of 13,705 shares on June 4 executed under a pre-arranged Rule 10b5-1 trading plan, though the transaction represented only a 7.67% reduction in his direct holdings. Meanwhile, new institutional stakes were disclosed by HSBC Holdings PLC and Y Intercept Hong Kong Ltd, reinforcing the stock’s appeal among professional investors. The company also filed for a $200 million at-the-market equity offering, providing financial flexibility to fund capacity expansion and product qualifications without immediate dilution pressure.
2026 Outlook and Key Areas to Monitor
Looking ahead, the August 3 release of Ichor’s second quarter 2026 financial results represents the most immediate and significant catalyst. Investors will scrutinize whether revenue landed within the $290 million to $310 million guided range and whether non-GAAP gross margin continued its upward trajectory toward the 15% target management has outlined for mid-to-late 2026. The global footprint realignment—including the ramp of the new Malaysia manufacturing facility and expansion of machining capacity in Mexico—will be evaluated for its contribution to structural margin improvement. Broader semiconductor industry dynamics also remain pivotal: sustained demand driven by gate-all-around architecture adoption, high-bandwidth memory expansion, and rising etch and deposition intensity directly benefit Ichor’s product portfolio. On the risk side, ongoing hiring and retention challenges in U.S. operations, potential customer concentration concerns, and the possibility of uneven EUV-related demand recovery into the second half of 2026 warrant monitoring. The company’s commercial space segment, currently a sub-5% revenue contributor with a medium-term goal of reaching 10%, offers an additional growth vector that could surprise to the upside if design wins continue converting into production orders. From what I see, the upcoming earnings report will be particularly telling on whether these trends are accelerating.
AI-Powered Trading Tools in Practice
In a market environment where speed and data-driven decision-making are increasingly critical, AI-powered trading tools have become a focal point for traders and investors seeking an analytical edge. Tickeron’s Trending AI Robots page features a curated selection of top-performing AI trading bots drawn from a broader universe of hundreds of bots actively trading thousands of tickers across global markets. Only those bots demonstrating the strongest performance metrics and most consistent results earn placement in this section, making it a valuable resource for identifying strategies with proven track records. The bots span a wide range of trading approaches, time horizons, and risk profiles, allowing users to explore AI-driven insights tailored to different investment styles. For those interested in integrating algorithmic intelligence into their trading workflow, exploring the Trending AI Robots page may uncover actionable strategies aligned with current market conditions. I find this resource helpful when evaluating names like ICHR alongside broader sector trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsMomentum Indicator for ICHR turns negative, indicating new downward trend
ICHR saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 71 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 42 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICHR's RSI Indicator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 60 cases where ICHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.683) is normal, around the industry mean (6.482). P/E Ratio (-33.248) is within average values for comparable stocks, (90.479). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment
Advertisement